{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:12:26Z","timestamp":1783098746078,"version":"3.54.6"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University - Berwick Campus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000942","name":"Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.yebeh.2022.108571","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T06:56:49Z","timestamp":1643439409000},"page":"108571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Electroclinical biomarkers of autoimmune encephalitis"],"prefix":"10.1016","volume":"128","author":[{"given":"Robb","family":"Wesselingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tarlinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kyndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Stankovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendyl","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Macdonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yebeh.2022.108571_b0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108571_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2022.108571_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: A systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.yebeh.2022.108571_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2018.12.015","article-title":"EEG findings in NMDA encephalitis - A systematic review","volume":"65","author":"Gillinder","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108571_b0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jneuroim.2019.03.010","article-title":"A review of EEG in anti-NMDA receptor encephalitis","volume":"332","author":"Freund","year":"2019","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108571_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNP.0b013e3182784729","article-title":"American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version","volume":"30","author":"Hirsch","year":"2013","journal-title":"J Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.yebeh.2022.108571_b0035","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/epi.12653","article-title":"Interrater agreement for Critical Care EEG Terminology","volume":"55","author":"Gaspard","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108571_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.yebeh.2022.108571_b0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/epi.16515","article-title":"Seizures in autoimmune encephalitis: Kindling the fire","volume":"61","author":"Wesselingh","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108571_b0050","article-title":"Continuous EEG findings in autoimmune encephalitis","author":"Moise","year":"2019","journal-title":"J Clin Neurophysiol"},{"issue":"10","key":"10.1016\/j.yebeh.2022.108571_b0055","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.clinph.2018.02.130","article-title":"Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis","volume":"129","author":"Steriade","year":"2018","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108571_b0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1550059416642660","article-title":"EEG findings may serve as a potential biomarker for anti-NMDA receptor encephalitis","volume":"48","author":"Foff","year":"2017","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.yebeh.2022.108571_b0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.wnp.0000229137.94384.fa","article-title":"Drug effects on EEG","volume":"23","author":"Blume","year":"2006","journal-title":"J Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108571_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2015","journal-title":"Brain"},{"issue":"42","key":"10.1016\/j.yebeh.2022.108571_b0075","doi-asserted-by":"crossref","first-page":"E9916","DOI":"10.1073\/pnas.1804846115","article-title":"NMDA-receptor antibodies alter cortical microcircuit dynamics","volume":"115","author":"Rosch","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.yebeh.2022.108571_b0080","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/brain\/awy107","article-title":"Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis","volume":"141","author":"Symmonds","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108571_b0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ebcr.2014.09.005","article-title":"Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis","volume":"2","author":"Probasco","year":"2014","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.yebeh.2022.108571_b0090","doi-asserted-by":"crossref","first-page":"107462","DOI":"10.1016\/j.yebeh.2020.107462","article-title":"Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review","volume":"112","author":"Roberto","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108571_b0095","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108571_b0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2022.108571_b0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2018.04.007","article-title":"Predictive values and specificity of electroencephalographic findings in autoimmune encephalitis diagnosis","volume":"84","author":"Limotai","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.yebeh.2022.108571_b0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/jnnp-2018-318376","article-title":"Predictive value of electroencephalography in anti-NMDA receptor encephalitis","volume":"89","author":"Sonderen","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2022.108571_b0115","first-page":"985","article-title":"Prognostic implications of periodic epileptiform discharges","volume":"66","author":"Orta","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2022.108571_b0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yebeh.2015.04.007","article-title":"Generalized periodic discharges: Pathophysiology and clinical considerations","volume":"49","author":"van Putten","year":"2015","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:46:48Z","timestamp":1761504408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":24,"alternative-id":["S1525505022000208"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108571","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electroclinical biomarkers of autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108571"}}